Literature DB >> 21246000

Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Wen-Ke Cai1, Hui Sima, Ben-Dong Chen, Guang-Shun Yang.   

Abstract

AIM: To study the association between hilar cholangiocarcinoma (HC) and pre-existing medical conditions.
METHODS: Three hundred and thirteen HC patients admitted to the Eastern Hepatobiliary Surgery Hospital (Shanghai, China) in 2000-2005 and 608 healthy controls were enrolled in this study. Association between HC and pre-existing medical conditions was studied with their adjusted odds ratio (OR) calculated by logistic regression analysis.
RESULTS: The prevalence of choledocholithiasis (adjusted OR = 2.704, P = 0.039), hepatolithiasis (adjusted OR = 3.278, P = 0.018), cholecystolithiasis (adjusted OR = 4.499, P < 0.0001), cholecystectomy (adjusted OR = 7.012, P = 0.004), biliary ascariasis (adjusted OR = 7.188, P = 0.001), liver fluke (adjusted OR = 10.088, P = 0.042) and liver schistosomiasis (adjusted OR = 9.913, P = 0.001) was higher in HC patients than in healthy controls.
CONCLUSION: Biliary tract stone disease (choledocholithiasis, hepatolithiasis, cholecystolithiasis) and parasitic liver disease (biliary ascariasis, liver fluke, liver schistosomiasis) are the risk factors for HC in Chinese population.

Entities:  

Keywords:  Choledocholithiasis; Hepatitis B virus; Hepatitis C virus; Hilar cholangiocarcinoma; Liver fluke

Mesh:

Year:  2011        PMID: 21246000      PMCID: PMC3020381          DOI: 10.3748/wjg.v17.i2.249

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.

Authors:  Ru-Fu Chen; Zhi-Hua Li; Sheng-Quan Zou; Ji-Sheng Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-02

2.  Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study.

Authors:  S Kurathong; P Lerdverasirikul; V Wongpaitoon; C Pramoolsinsap; A Kanjanapitak; W Varavithya; P Phuapradit; S Bunyaratvej; E S Upatham; W Y Brockelman
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

3.  Chronic schistosomiasis japonica is an independent adverse prognostic factor for survival in hepatocellular carcinoma patients who have undergone hepatic resection: clinicopathological and prognostic analysis of 198 consecutive patients.

Authors:  Masanori Matsuda; Hideki Fujii
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

4.  Risk factors in primary sclerosing cholangitis.

Authors:  E Schrumpf; M Abdelnoor; O Fausa; K Elgjo; E Jenssen; F Kolmannskog
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

5.  Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea.

Authors:  Dongil Choi; Jae Hoon Lim; Kyu Taek Lee; Jong Kyun Lee; Seong Ho Choi; Jin Seok Heo; Kee-Taek Jang; Nam Yong Lee; Seonwoo Kim; Sung-Tae Hong
Journal:  J Hepatol       Date:  2005-12-27       Impact factor: 25.083

6.  Hilar cholangiocarcinoma: diagnosis and staging.

Authors:  William Jarnagin; Corinne Winston
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

7.  Biliary ascariasis: surgical aspects.

Authors:  N A Wani; R K Chrungoo
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

8.  Hepatitis B virus and intrahepatic cholangiocarcinoma.

Authors:  Nikolaos K Gatselis; Konstantinos Tepetes; Argirios Loukopoulos; Katerina Vasiou; Athanasios Zafiriou; Chrisoula Gioti; Georgios N Dalekos
Journal:  Cancer Invest       Date:  2007-02       Impact factor: 2.176

9.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

10.  Risk of extrahepatic bileduct cancer after cholecystectomy.

Authors:  A Ekbom; C C Hsieh; J Yuen; D Trichopoulos; J K McLaughlin; S J Lan; H O Adami
Journal:  Lancet       Date:  1993-11-20       Impact factor: 79.321

View more
  16 in total

1.  Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.

Authors:  Jie-Hui Tan; Wan-Yan Zhou; Lei Zhou; Rong-Chang Cao; Guo-Wei Zhang
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

2.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Authors:  Ban Seok Lee; Eun-Cheol Park; Seung Woo Park; Chung Mo Nam; Jaehoon Roh
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 3.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

Review 4.  Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.

Authors:  Xiao-Hua Ye; Jia-Ping Huai; Jin Ding; Yan-Ping Chen; Xue-Cheng Sun
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 5.  Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis.

Authors:  Jing Xia; Shi-chen Jiang; Hong-Juan Peng
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 6.  Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.

Authors:  Hao Li; Bin Hu; Zun-Qiang Zhou; Jiao Guan; Zheng-Yun Zhang; Guang-Wen Zhou
Journal:  World J Surg Oncol       Date:  2015-04-23       Impact factor: 2.754

Review 7.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

8.  The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma.

Authors:  Men-Bao Qian; Ying-Dan Chen; Song Liang; Guo-Jing Yang; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2012-10-25       Impact factor: 4.520

9.  Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.

Authors:  Jeffrey S Chang; Chia-Rung Tsai; Li-Tzong Chen
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

10.  Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis.

Authors:  Junshan Li; Tianjie Han; Linlin Xu; Xiaotian Luan
Journal:  Prz Gastroenterol       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.